BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25027012)

  • 1. The association between the LRRK2 G2385R variant and the risk of Parkinson's disease: a meta-analysis based on 23 case-control studies.
    Xie CL; Pan JL; Wang WW; Zhang Y; Zhang SF; Gan J; Liu ZG
    Neurol Sci; 2014 Oct; 35(10):1495-504. PubMed ID: 25027012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease.
    Liu J; Zhou Y; Wang C; Wang T; Zheng Z; Chan P
    Parkinsonism Relat Disord; 2012 Feb; 18(2):140-3. PubMed ID: 21924942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex effects on clinical features in LRRK2 G2385R carriers and non-carriers in Parkinson's disease.
    Cui SS; Fu R; Du JJ; Lin YQ; Huang P; Gao C; Zhou HY; Chen SD
    BMC Neurosci; 2021 Mar; 22(1):22. PubMed ID: 33771108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The LRRK2 G2385R variant is a risk factor for sporadic Parkinson's disease in the Korean population.
    Kim JM; Lee JY; Kim HJ; Kim JS; Shin ES; Cho JH; Park SS; Jeon BS
    Parkinsonism Relat Disord; 2010 Feb; 16(2):85-8. PubMed ID: 19854095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between the LRRK2 R1628P variant and the risk of Parkinson's disease in Asian: a meta-analysis.
    Wang X; Zhang X; Xue L; Xie A
    Neurosci Lett; 2016 Jun; 623():22-7. PubMed ID: 27133195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRRK2 G2385R variant carriers of female Parkinson's disease are more susceptible to motor fluctuation.
    Gao C; Pang H; Luo XG; Ren Y; Shang H; He ZY
    J Neurol; 2013 Nov; 260(11):2884-9. PubMed ID: 24046064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.
    Ross OA; Soto-Ortolaza AI; Heckman MG; Aasly JO; Abahuni N; Annesi G; Bacon JA; Bardien S; Bozi M; Brice A; Brighina L; Van Broeckhoven C; Carr J; Chartier-Harlin MC; Dardiotis E; Dickson DW; Diehl NN; Elbaz A; Ferrarese C; Ferraris A; Fiske B; Gibson JM; Gibson R; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lesage S; Lin CH; Lynch T; Maraganore DM; Mellick GD; Mutez E; Nilsson C; Opala G; Park SS; Puschmann A; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Theuns J; Tomiyama H; Uitti RJ; Valente EM; van de Loo S; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Farrer MJ;
    Lancet Neurol; 2011 Oct; 10(10):898-908. PubMed ID: 21885347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAPT IVS1+124 C>G modifies risk of LRRK2 G2385R for Parkinson's disease in Chinese individuals.
    Dan X; Wang C; Ma J; Feng X; Wang T; Zheng Z; Chan P
    Neurobiol Aging; 2014 Jul; 35(7):1780.e7-1780.e10. PubMed ID: 24559644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between LRRK2 gene G2385R polymorphisms and Parkinson's disease.
    Yan H; Ma Q; Yang X; Wang Y; Yao Y; Li H
    Mol Med Rep; 2012 Oct; 6(4):879-83. PubMed ID: 22842796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between G2385R and R1628P polymorphism of LRRK2 gene and sporadic Parkinson's disease in a Han-Chinese population in south-eastern China.
    Cai J; Lin Y; Chen W; Lin Q; Cai B; Wang N; Zheng W
    Neurol Sci; 2013 Nov; 34(11):2001-6. PubMed ID: 23624603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SNCA but not DNM3 and GAK modifies age at onset of LRRK2-related Parkinson's disease in Chinese population.
    Yang ZH; Li YS; Shi MM; Yang J; Liu YT; Mao CY; Fan Y; Hu XC; Shi CH; Xu YM
    J Neurol; 2019 Jul; 266(7):1796-1800. PubMed ID: 31041581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease.
    Zabetian CP; Yamamoto M; Lopez AN; Ujike H; Mata IF; Izumi Y; Kaji R; Maruyama H; Morino H; Oda M; Hutter CM; Edwards KL; Schellenberg GD; Tsuang DW; Yearout D; Larson EB; Kawakami H
    Mov Disord; 2009 May; 24(7):1034-41. PubMed ID: 19343804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatigue correlates with LRRK2 G2385R variant in Chinese Parkinson's disease patients.
    Fu R; Cui SS; Du JJ; He YC; Gao C; Huang P; Qian YW; Luo XG; Chen SD
    Parkinsonism Relat Disord; 2017 Nov; 44():101-105. PubMed ID: 28941828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative assessment of the effect of LRRK2 exonic variants on the risk of Parkinson's disease: a meta-analysis.
    Wu X; Tang KF; Li Y; Xiong YY; Shen L; Wei ZY; Zhou KJ; Niu JM; Han X; Yang L; Feng GY; He L; Qin SY
    Parkinsonism Relat Disord; 2012 Jul; 18(6):722-30. PubMed ID: 22575234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the role of LRRK2 gene in Parkinson's disease in an East Indian cohort.
    Sadhukhan T; Vishal M; Das G; Sharma A; Mukhopadhyay A; Das SK; Ray K; Ray J
    Dis Markers; 2012; 32(6):355-62. PubMed ID: 22684232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penetrance of Parkinson disease LRRK2 G2385R-associated variant in the Chinese population.
    Wang P; Cui P; Luo Q; Chen J; Tang H; Zhang L; Chen S; Ma J
    Eur J Neurol; 2022 Sep; 29(9):2639-2644. PubMed ID: 35608967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association between LRRK2 G2385R and cognitive dysfunction in Korean patients with Parkinson's disease.
    Hong JH; Kim YK; Park JS; Lee JE; Oh MS; Chung EJ; Kim JY; Sung YH; Lyoo CH; Lee JH; Kwon DY; Kim HS; Shin HW; Park SA; Park IS; Kim JS; Lee PH; Koh SB; Baik JS; Kim SJ; Ma HI; Kim JW; Kim YJ
    J Clin Neurosci; 2017 Feb; 36():108-113. PubMed ID: 27839916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The G2385R variant of leucine-rich repeat kinase 2 associated with Parkinson's disease is a partial loss-of-function mutation.
    Rudenko IN; Kaganovich A; Hauser DN; Beylina A; Chia R; Ding J; Maric D; Jaffe H; Cookson MR
    Biochem J; 2012 Aug; 446(1):99-111. PubMed ID: 22612223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LRRK2 G2385R and R1628P mutations are associated with an increased risk of Parkinson's disease in the Malaysian population.
    Gopalai AA; Lim SY; Chua JY; Tey S; Lim TT; Mohamed Ibrahim N; Tan AH; Eow GB; Abdul Aziz Z; Puvanarajah SD; Viswanathan S; Looi I; Lim SK; Tan LP; Chong YB; Tan CT; Zhao Y; Tan EK; Ahmad-Annuar A
    Biomed Res Int; 2014; 2014():867321. PubMed ID: 25243190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRRK2 R1628P contributes to Parkinson's disease susceptibility in Chinese Han populations from mainland China.
    Yu L; Hu F; Zou X; Jiang Y; Liu Y; He X; Xi J; Liu L; Liu Z; He L; Xu Y
    Brain Res; 2009 Nov; 1296():113-6. PubMed ID: 19699188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.